openPR Logo
Press release

Cluster Headache Market Forecast: Projected Compound Growth Rate At 3.9 % CAGR and Growth Opportunities 2031

08-25-2023 12:50 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Cluster Headache Market Forecast: Projected Compound Growth

The global cluster headache industry generated $356.00 million in 2021, and is estimated to reach $522.98 million by 2031, witnessing a CAGR of 3.9% from 2022 to 2031.

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/14812

Market Growth: The cluster headache market has witnessed steady growth in recent years due to increasing awareness, improved diagnostic techniques, and a better understanding of the condition. The market is expected to continue growing as more effective treatments become available.

Limited Treatment Options: Historically, cluster headaches have been challenging to treat, and there is no cure for the condition. Patients often struggle to find relief, and the available treatment options have been limited. This has created a significant unmet need for better therapies.

Oxygen Therapy: One of the most effective acute treatments for cluster headaches is oxygen therapy, where high-flow oxygen is administered through a mask. This helps alleviate pain and shorten the duration of the headache. Oxygen therapy remains a standard treatment option and is widely recommended.

Triptans and Gammacore: Triptans, a class of medications commonly used for migraines, are also prescribed for cluster headaches. They help alleviate pain and reduce the frequency of attacks. Additionally, non-invasive vagus nerve stimulation devices, such as Gammacore, have shown promise in providing relief from cluster headache attacks.

Market Segmentation:

By Treatment Type:
a. Acute Treatments: This segment includes medications and therapies used to relieve the symptoms of an acute cluster headache attack. It may encompass oxygen therapy, triptans, non-invasive vagus nerve stimulation devices, and other acute treatment options.
b. Preventive Treatments: This segment includes medications and therapies used to prevent or reduce the frequency and severity of cluster headache attacks. Preventive treatments may include medications such as verapamil, lithium, corticosteroids, and emerging therapies like calcitonin gene-related peptide (CGRP) monoclonal antibodies.

By Distribution Channel:
a. Hospital Pharmacies: This segment includes medications and treatments dispensed through hospital pharmacies, often prescribed by healthcare professionals specializing in headache disorders.
b. Retail Pharmacies: This segment includes medications and treatments available over the counter or through prescription from retail pharmacies, making them more accessible to patients.
c. Online Pharmacies: This segment encompasses medications and treatments available for purchase through online platforms, offering convenience and access to a wider range of products.

By Geography:
a. North America: This segment includes the cluster headache market in countries such as the United States and Canada.
b. Europe: This segment includes the cluster headache market in countries like the United Kingdom, Germany, France, Italy, and other European nations.
c. Asia-Pacific: This segment includes the cluster headache market in countries such as China, Japan, India, Australia, and other Asia-Pacific nations.
d. Latin America: This segment includes the cluster headache market in countries such as Brazil, Mexico, Argentina, and other Latin American nations.
e. Middle East and Africa: This segment includes the cluster headache market in countries across the Middle East and Africa region.

By End User:
a. Hospitals and Clinics: This segment includes treatments and therapies administered within hospital settings or specialized headache clinics.
b. Homecare: This segment includes treatments and therapies that can be self-administered or provided by caregivers in a home setting.
c. Research Institutes and Academic Centers: This segment includes institutions engaged in clinical research, trials, and academic studies related to cluster headaches.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/14812

Competitive Landscape:

Arrotex Australia Group
AstraZeneca
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
Fresenius SE & Co. KGaA
GlaxoSmithKline plc
Novartis AG
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14812

Related Reports :

Immunoprotein Diagnostic Testing Market https://www.alliedmarketresearch.com/immunoprotein-diagnostic-testing-market

Metabolomics Market https://www.alliedmarketresearch.com/metabolomics-market

Early Toxicity Testing Market https://www.alliedmarketresearch.com/early-toxicity-testing-market

Vertebral Compression Fracture Devices Market https://www.alliedmarketresearch.com/vertebral-compression-fracture-devices-market

Oncology Information System Market https://www.alliedmarketresearch.com/oncology-information-system-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cluster Headache Market Forecast: Projected Compound Growth Rate At 3.9 % CAGR and Growth Opportunities 2031 here

News-ID: 3181851 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any